Piotr P. Witkowski to Diabetes Mellitus, Type 1
This is a "connection" page, showing publications Piotr P. Witkowski has written about Diabetes Mellitus, Type 1.
Connection Strength
3.612
-
207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Transplantation. 2021 12 01; 105(12 Suppl 1):S3.
Score: 0.560
-
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States. Am J Transplant. 2021 07; 21(7):2620-2622.
Score: 0.533
-
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update. Am J Transplant. 2021 04; 21(4):1365-1375.
Score: 0.529
-
Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant. 2018 04; 18(4):990-997.
Score: 0.428
-
Islet transplantation for type 1 diabetes--where should we go? Nat Clin Pract Endocrinol Metab. 2007 Jan; 3(1):2-3.
Score: 0.199
-
Pancreatic islet transplantation, what has been achieved since Edmonton break-through. Ann Transplant. 2006; 11(2):5-13; discussion 32-43.
Score: 0.186
-
Long-term effects of pancreatic islet transplantation on polyneuropathy in patients with brittle diabetes: A single-center experience. Muscle Nerve. 2023 09; 68(3):329-333.
Score: 0.156
-
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry. Diabetologia. 2023 01; 66(1):163-173.
Score: 0.148
-
Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes. Diabetes Care. 2020 04; 43(4):710-718.
Score: 0.123
-
BETA-2 score is an early predictor of graft decline and loss of insulin independence after pancreatic islet allotransplantation. Am J Transplant. 2020 03; 20(3):844-851.
Score: 0.121
-
Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes. Cell Stem Cell. 2018 01 04; 22(1):78-90.e4.
Score: 0.107
-
External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment. Transplant Proc. 2017 Dec; 49(10):2340-2346.
Score: 0.106
-
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes. J Transl Med. 2016 12 01; 14(1):332.
Score: 0.099
-
Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes. Endocrine. 2015 Aug; 49(3):693-702.
Score: 0.087
-
Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. Clin Immunol. 2014 Jul; 153(1):23-30.
Score: 0.082
-
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012 Jul; 35(7):1436-45.
Score: 0.073
-
Administration of CD4+CD25highCD127- regulatory T cells preserves ß-cell function in type 1 diabetes in children. Diabetes Care. 2012 Sep; 35(9):1817-20.
Score: 0.073